Advertisement
U.S. Markets open in 59 mins

China SXT Pharmaceuticals, Inc. (SXTC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
0.6794+0.0493 (+7.82%)
At close: 04:00PM EDT
0.6880 +0.02 (+2.69%)
Pre-Market: 08:29AM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
1,928
1,928
1,972
2,602
4,778
-
Cost of Revenue
1,375
1,375
1,545
1,351
1,938
-
Gross Profit
553.971
553.971
426.271
1,252
2,840
-
Operating Expense
3,069
3,069
6,034
6,441
5,037
-
Operating Income
-2,515
-2,515
-5,608
-5,190
-2,197
-
Net Non Operating Interest Income Expense
-544.279
-544.279
-476.776
-36.695
-1,615
-
Other Income Expense
-39.036
-39.036
149.513
-181.581
871.65
-
Pretax Income
-3,099
-3,099
-5,935
-5,408
-2,941
-
Tax Provision
0
0
0
328.146
-192.683
-
Net Income Common Stockholders
-3,099
-3,099
-5,935
-5,736
-2,748
-
Diluted NI Available to Com Stockholders
-3,099
-3,099
-5,935
-5,736
-2,748
-
Basic EPS
-22.23
-3.57
-22.23
-137.92
-95.47
-
Diluted EPS
-22.23
-3.57
-22.23
-137.92
-95.47
-
Basic Average Shares
266.973
867.422
266.973
41.591
28.781
-
Diluted Average Shares
266.973
867.422
266.973
41.591
28.781
-
Total Operating Income as Reported
-2,515
-2,515
-5,608
-5,190
-2,197
-
Total Expenses
4,444
4,444
7,579
7,792
6,975
-
Net Income from Continuing & Discontinued Operation
-3,099
-3,099
-5,935
-5,736
-2,748
-
Normalized Income
-3,099
-3,099
-5,935
-5,736
-2,748
-
Interest Expense
544.279
544.279
476.776
36.695
-
-
Net Interest Income
-544.279
-544.279
-476.776
-36.695
-1,615
-
EBIT
-2,554
-2,554
-5,458
-5,371
-2,197
-
EBITDA
-2,351
-2,351
-5,208
-5,051
-1,852
-
Reconciled Cost of Revenue
1,375
1,375
1,545
1,351
1,938
-
Reconciled Depreciation
203.247
203.247
250.162
320.007
345.414
-
Net Income from Continuing Operation Net Minority Interest
-3,099
-3,099
-5,935
-5,736
-2,748
-
Total Unusual Items Excluding Goodwill
-
-
-
0
0
-5,626
Total Unusual Items
-
-
-
0
0
-5,626
Normalized EBITDA
-2,351
-2,351
-5,208
-5,051
-1,852
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-